Skip to main navigation
ArriVent Biopharma logo
  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Corporate Governance
    • Governance Documents
    • Executive Team
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Investor Contact
ArriVent Biopharma image

Quarterly Results

Financial Information
  • SEC Filings
Show all

2026

Q1

  • ArriVent BioPharma Reports First Quarter 2026 Financial Results
  • Form 10-Q

2025

Q4

  • ArriVent BioPharma Reports Full Year 2025 Financial Results
  • Form 10-K

Q3

  • ArriVent BioPharma Reports Third Quarter 2025 Financial Results
  • Form 10-Q

Q2

  • ArriVent BioPharma Reports Second Quarter 2025 Financial Results
  • Form 10-Q

Q1

  • ArriVent BioPharma Reports First Quarter 2025 Financial Results
  • Form 10-Q

2024

Q4

  • ArriVent BioPharma Reports Full Year 2024 Financial Results
  • Form 10-K

Q3

  • ArriVent BioPharma Reports Third Quarter 2024 Financial Results
  • Form 10-Q

Q2

  • ArriVent BioPharma Reports Second Quarter 2024 Financial Results
  • Form 10-Q

Q1

  • ArriVent BioPharma Reports First Quarter 2024 Financial Results
  • Form 10-Q

2023

Q4

  • ArriVent BioPharma Reports Full Year 2023 Financial Results
  • Form 10-K
drafts jallaire@lifesciadvisors.com
©2026 ArriVent Biopharma, Inc. All rights reserved.
ARRIVENT and  Reg. U.S. Pat. & Tm. Off.
Search Investors